2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
47
Lung Neoplasms
28
Neoplasms
27
Colorectal Neoplasms
21
Prostatic Neoplasms
16
Hematologic Neoplasms
10
Uterine Cervical Neoplasms
9
Fatigue
9
Anxiety Disorders
8
Neoplasm Metastasis
7
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Papillomavirus Infections
6
Melanoma
6
Ovarian Neoplasms
5
Multiple Myeloma
5
Head and Neck Neoplasms
5
Gastrointestinal Neoplasms
5
Depression
5
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Skin Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Interventions
Gemcitabine
30
Mitomycin
25
BCG Vaccine
13
Docetaxel
10
Epirubicin
6
erdafitinib
5
durvalumab
5
dodecyl maltoside
5
Radiotherapy
5
Cystoscopy
5
apaziquone
4
ALT-803
4
tislelizumab
3
5-aminolevulinic acid hexyl ester
3
viscum album peptide
2
pembrolizumab
2
disitamab vedotin
2
avelumab
2
VB4-845
2
Therapeutics
2
Imiquimod
2
Hyaluronic Acid
2
Administration, Intravesical
2
1-phenyl-3,3-dimethyltriazene
2
vocimagene amiretrorepvec
1
valrubicin
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Educational Status
×
Clear all
NCT05154084
2023-11-14
RESECT
British Urology Researchers in Surgical Training
Completed
19,505 enrolled